NAC CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 525 JPY | 0.00% |
|
-0.19% | +5.85% |
| Apr. 17 | NAOS Ex-50 Declares Quarterly Dividend | MT |
| Apr. 03 | ARS Pharmaceuticals Submits Response to FDA Letter for Neffy | DJ |
| Sales 2022 | 54.92B 354M | Sales 2023 | 57.07B 368M | Capitalization | 21.45B 138M |
|---|---|---|---|---|---|
| Net income 2022 | 1.71B 11M | Net income 2023 | 2B 12.89M | EV / Sales 2022 | 0.33 x |
| Net cash position 2022 | 3.45B 22.25M | Net cash position 2023 | 3.8B 24.46M | EV / Sales 2023 | 0.31 x |
| P/E ratio 2022 |
12.5
x | P/E ratio 2023 |
10.7
x | Employees | 1,591 |
| Yield 2022 |
3.99% | Yield 2023 |
4.18% | Free-Float | 29.06% |
More Fundamentals
* Assessed data
More news
More recommendations
More news
| 1 week | -0.19% | ||
| Current month | -2.78% | ||
| 1 month | -9.79% | ||
| 3 months | -1.50% | ||
| 6 months | +9.95% | ||
| Current year | +5.85% |
1 week
512.00
527.00
1 month
512.00588.00
Current year
494.00588.00
1 year
473.00588.00
3 years
446.00588.00
5 years
328.50655.00
10 years
328.50784.50
| Managers | Title | Age | Since |
|---|---|---|---|
Yuji Ii
DFI | Director of Finance/CFO | - | - |
Kan Yoshimura
PSD | President | 62 | 84-03-31 |
Hiroaki Oshima
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hiroo Shimada
BRD | Director/Board Member | 81 | 15-05-31 |
Kan Yoshimura
PSD | President | 62 | 84-03-31 |
Kenichi Miyajima
BRD | Director/Board Member | 69 | 21-06-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 19 M€ | +4.43% | ||
| 0.00% | 18 M€ | +16.15% | - | |
| 0.00% | 144,586 M€ | +15.56% | ||
| 0.00% | 66,066 M€ | +15.66% | - | |
| 0.00% | 20,721 M€ | +14.49% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 525 | 0.00% | 16,400 |
| 24-04-23 | 525 | +0.57% | 16,700 |
| 24-04-22 | 522 | +1.16% | 26,800 |
| 24-04-19 | 516 | -1.34% | 57,600 |
| 24-04-18 | 523 | +0.38% | 24,900 |
Delayed Quote Japan Exchange, April 24, 2024 at 02:00 am EDT
More quotes
NAC CO., LTD. mainly operates real estate business. It has five segments. The CreCla segment is engaged in the manufacture and sale of bottled mineral water under the name CreCla in Japan. The Rental segment is engaged in the rental and sale of dust control products, the rental of pest control equipment, as well as the cleaning business. The Construction Consulting segment is engaged in the sale of know-how products and building materials to construction shops, as well as the provision of consulting services. The Housing segment is engaged in the construction contracts for detached houses and the sale of condominiums and the related financial and insurance services. The Mail-Order segment provides cosmetics, health foods and alcoholic beverages.
Sector
Homebuilding
Calendar
2024-05-14
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +5.85% | 146M | |
| -3.86% | 48.88B | |
| +8.76% | 23.79B | |
| +2.06% | 17.93B | |
| +15.49% | 14.5B | |
| +15.48% | 12.45B | |
| -0.90% | 6.16B | |
| +14.66% | 6.11B | |
| +11.19% | 6.06B | |
| +5.62% | 6.06B |
- Stock Market
- Equities
- 9788 Stock
